clinical study of positron emission tomography with 3-deoxy-3-[18F]-fluoro-D-glucose

clinical study of positron emission tomography with 3-deoxy-3-[18F]-fluoro-D-glucose - Clinical study in 3FDG-PET

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008871

Enrollment

100

Registered

2012-09-07

Start date

2012-09-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adult volunteer, cancer, epilepsy, Moyamoya disease,Alzheimer&#39

Interventions

MRI/CT/EEG/clinical examinations

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy volunteers between 20 and 70 years cognitive normal subjects without severe physical complication patients with cancer diagnosis between 20 and 70 years

Exclusion criteria

Exclusion criteria: exclude the patients who are recognized as inadequate patients by doctors with resposibility in this study

Design outcomes

Primary

Measure	Time frame
visualization of the lesion	—

Secondary

Measure	Time frame
Confirmation of the differences between 3FDG-PET and conventional 2FDG-PET	—

Countries

Japan

Contacts

Public ContactYuji Suzuki

University of Niigata Center for Integrated Human Brain Science

yuji-s@bri.niigata-u.ac.jp025-227-0683

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026